scholarly journals Noncovalent interactions dominate dynamic heme distortion in cytochrome P450 4B1

2018 ◽  
Vol 293 (29) ◽  
pp. 11433-11446 ◽  
Author(s):  
Gareth K. Jennings ◽  
Mei-Hui Hsu ◽  
Lisa S. Shock ◽  
Eric F. Johnson ◽  
John C Hackett
Keyword(s):  
Cytochrome P450 ◽  
Noncovalent Interactions ◽  
Cytochrome P450 4B1 ◽  
Heme Distortion

scholarly journals Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: Implications for pharmacogene therapy

2002 ◽  
Vol 9 (2) ◽  
pp. 178-188 ◽  
Author(s):  
Susanne Frank ◽  
Sabine Steffens ◽  
Ute Fischer ◽  
Aurelia Tlolko ◽  
Nikolai G Rainov ◽  
...  
Keyword(s):  
Cytochrome P450 ◽  
Bystander Effect ◽  
Enzyme Gene ◽  
Cytochrome P450 4B1

New Prodrug Activation Gene Therapy for Cancer Using Cytochrome P450 4B1 and 2-Aminoanthracene/4-Ipomeanol

1998 ◽  
Vol 9 (9) ◽  
pp. 1261-1273 ◽  
Author(s):  
Nikolai G. Rainov ◽  
Karl-Ulrich Dobberstein ◽  
Miguel Sena-Esteves ◽  
Ulrich Herrlinger ◽  
Christof M. Kramm ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Cytochrome P450 ◽  
Prodrug Activation ◽  
Cytochrome P450 4B1

scholarly journals Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1

2007 ◽  
Vol 84 (3-4) ◽  
pp. 116-127 ◽  
Author(s):  
Francesca Seta ◽  
Kiran Patil ◽  
Lars Bellner ◽  
Alexandre Mezentsev ◽  
Rowena Kemp ◽  
...  
Keyword(s):  
Cytochrome P450 ◽  
Corneal Neovascularization ◽  
Vegf Expression ◽  
Cytochrome P450 4B1

scholarly journals Rabbit cytochrome P450 4B1: A novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma

2000 ◽  
Vol 7 (7) ◽  
pp. 1008-1014 ◽  
Author(s):  
Leonhard Mohr ◽  
Nikolai G Rainov ◽  
Ursula G Mohr ◽  
Jack R Wands
Keyword(s):  
Hepatocellular Carcinoma ◽  
Cytochrome P450 ◽  
Cytochrome P450 4B1

scholarly journals Suppression of cytochrome P450 4B1: An early event in adrenocortical tumorigenesis

Surgery ◽  
2017 ◽  
Vol 161 (1) ◽  
pp. 257-263 ◽  
Author(s):  
Timothy D. Murtha ◽  
Reju Korah ◽  
Tobias Carling
Keyword(s):  
Cytochrome P450 ◽  
Early Event ◽  
Cytochrome P450 4B1

scholarly journals Prodrug-activating Gene Therapy with Rabbit Cytochrome P450 4B1/4-Ipomeanol or 2-Aminoanthracene System in Glioma Cells

2010 ◽  
Vol 44 (3) ◽  
pp. 193-198 ◽  
Author(s):  
Su Jin Jang ◽  
Joo Hyun Kang ◽  
Tae Sup Lee ◽  
Sung Joo Kim ◽  
Kwang Il Kim ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Cytochrome P450 ◽  
Glioma Cells ◽  
Cytochrome P450 4B1

4-Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T12 cells expressing rabbit cytochrome P450 4B1

1995 ◽  
Vol 50 (10) ◽  
pp. 1567-1575 ◽  
Author(s):  
P.Blaise Smith ◽  
Howard F. Tiano ◽  
Stephen Nesnow ◽  
Michael R. Boyd ◽  
Richard M. Philpot ◽  
...  
Keyword(s):  
Cytochrome P450 ◽  
Cytochrome P450 4B1

Downregulation of the cytochrome P450 4B1 protein confers a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder

Apmis ◽  
2019 ◽  
Vol 127 (4) ◽  
pp. 170-180 ◽  
Author(s):  
Jen‐Tai Lin ◽  
Ti‐Chun Chan ◽  
Chien‐Feng Li ◽  
Steven K.H. Huan ◽  
Yu‐Feng Tian ◽  
...  
Keyword(s):  
Cytochrome P450 ◽  
Prognostic Factor ◽  
Urinary Bladder ◽  
Poor Prognostic Factor ◽  
Urothelial Carcinomas ◽  
Cytochrome P450 4B1
Sign in / Sign up

Export Citation Format

Share Document